| Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127) |
|---|
| 01/21/2009 | CN101347480A Effective component of inula flower and preparation and use thereof |
| 01/21/2009 | CN100453538C Preparation for chemical composition of Shenmai injection and application in treating cardiovascular and cerebrovascular diseases thereof |
| 01/20/2009 | CA2391239C Benzopyran derivative and antiallergic agent |
| 01/15/2009 | WO2009008980A2 Tetrahydropyranochromene gamma secretase inhibitors |
| 01/15/2009 | US20090018185 Compositions and products containing s-equol, and methods for their making |
| 01/15/2009 | US20090018167 angiogenesis inhibitors such as 1-phenyl-3-pyridin-2-ylprop-2-en-1-one, having antitumor and anticarcinogenic activity; treatment of skin disorders such as psoriasis, acne, rosacea, warts, eczema, hemangiomas, and lymphangiogenesis, as well as chronic inflammatory disease such as arthritis |
| 01/15/2009 | CA2691542A1 Tetrahydropyranochromene gamma secretase inhibitors |
| 01/14/2009 | EP2014285A1 NPYY5 antagonists |
| 01/14/2009 | EP2013163A1 Tetrasubstituted ureas as modulators of 11-beta hydroxyl steroid dehydrogenase type 1 |
| 01/14/2009 | EP1871757B1 Process for the manufacture of hydroxylated isoflavones |
| 01/14/2009 | CN101346663A Photochromic 2H-naphthopyrans |
| 01/14/2009 | CN101346648A Photochromic materials having electron-withdrawing substituents |
| 01/14/2009 | CN101346366A Benzochromene derivatives |
| 01/14/2009 | CN101346365A Agent for treatment of circulatory failure |
| 01/14/2009 | CN101343270A Method for extracting tea polyphenol and theine from tea simultaneously |
| 01/14/2009 | CN100451028C Antiinflammation compound |
| 01/14/2009 | CN100451013C Producing technique for extracting extract products of amentoflavone |
| 01/14/2009 | CN100450994C Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 01/13/2009 | US7476744 Polymorphic crystalline forms of celecoxib |
| 01/13/2009 | US7476741 Treating proliferative disorders such as cancer, autoimmune or inflammatory diseases such as psoriasis; e.g. 4-(3-Bromo-4,5-dimethoxyphenyl)-3-cyano-7-dimethylamino-4H-chromene; use with known anticancer drugs or radiotherapy |
| 01/13/2009 | US7476686 e.g. 1-(Benzofuran-2-carbonyl-3-(3-phenoxy-phenyl)-thiourea; viricides; Hepatitis C infection |
| 01/13/2009 | US7476673 4-[3-Hydroxyimino-3-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-propenyl]-benzoic acid; emphysema; respiratory system and skin disorder; acne and psoriasis; side effect reduction; improved pharmacology |
| 01/08/2009 | WO2009006580A1 Optionally condensed dihydropyridine, dihydropyrimidine and dihydropyrane derivatives acting as late sodium channel blockers |
| 01/08/2009 | WO2009003229A1 2-substituted isoflavonoid compounds, medicaments and uses |
| 01/08/2009 | US20090011454 Fluorescent Sensors for Cellular Amines |
| 01/08/2009 | CA2691201A1 2-substituted isoflavonoid compounds, medicaments and uses |
| 01/07/2009 | EP2010511A1 Chromen-2-one derivatives |
| 01/07/2009 | EP2010505A2 Heterocyclic compounds and uses thereof in the treatment of sexual disorders |
| 01/07/2009 | EP1718568A4 Process for preparing water soluble diterpenes and their applications |
| 01/07/2009 | EP1687291A4 Novel cyclic oxygenated compounds having cooling, fragrance, and flavor properties, and uses thereof |
| 01/07/2009 | EP1604231B9 Photochromic ocular devices |
| 01/07/2009 | EP1390332B1 Uncatalysed addition reactions |
| 01/07/2009 | CN101341141A Photochromic indeno-fused naphthopyrans |
| 01/07/2009 | CN101341140A Benzochromene derivatives for use in liquid crystal media and as therapeutic active substances |
| 01/07/2009 | CN101337957A Scutellarin derivates, preparation method and application thereof |
| 01/07/2009 | CN101337956A Scutellarein carbamate derivates, preparation method and application thereof |
| 01/07/2009 | CN101337882A Method for purifying rupestonic acid and chrysosplenetin B by high speed reversed flow chromatography |
| 01/07/2009 | CN101336949A Method for extracting polysaccharide and flavone from Gynura divaricata |
| 01/07/2009 | CN100448880C 2'oxo-voruscharin and derivatives thereof |
| 01/07/2009 | CN100448863C 抗生素化合物 Antibiotic compound |
| 01/07/2009 | CN100448850C Amino 1, 3, 5-triazines n-substituted with chiral bicyclic radicals, process for their preparation, compositions thereof and their use as herbicides and plant growth regulators |
| 01/01/2009 | US20090007292 Corn inbreds like far045 and hybrids thereof |
| 01/01/2009 | US20090005580 Compounds, compositions and methods |
| 01/01/2009 | US20090005437 Alpha-Ketoglutarates and Their Use as Therapeutic Agents |
| 01/01/2009 | US20090005436 Substituted Aminoalkyl- and Amidoalkyl-Benzopyran Derivatives |
| 01/01/2009 | US20090004485 6-member ring structure used in electroluminescent devices |
| 01/01/2009 | US20090004108 Smmr (Small Molecule Metabolite Reporters) For Use As In Vivo Glucose Biosensors |
| 01/01/2009 | US20090001353 1,6-dithiapyrene compounds; thin-film, field-effect transistor formed by low-temperature sublimation or solution-phase deposition onto substrate; integrated circuits; solar cells |
| 12/31/2008 | WO2009000775A1 Post-screening labeling of on-bead compounds |
| 12/31/2008 | EP1641772B1 Manufacture of tocopherols using a bismuth catalyst |
| 12/31/2008 | EP1481973B1 Heterocycle-bearing onium salts |
| 12/31/2008 | CN101333205A Baicalin piperazine of cyclin-dependent kinases and preparation method thereof |
| 12/31/2008 | CN101333204A Method for extracting dihydroquercetin form larch |
| 12/31/2008 | CN101333203A Method for extracting dihydroquercetin form larch |
| 12/31/2008 | CN101333202A Technique of preparing high-purity wogonin by extraction and separation method |
| 12/30/2008 | US7470798 7,8-bicycloalkyl-chroman derivatives |
| 12/30/2008 | CA2400237C Pluraflavins and derivatives thereof, process for their preparation and use thereof |
| 12/30/2008 | CA2395652C New derivatives of benzo[b]pyrano[3,2-h]acridin-7-one, process for preparing them, and pharmaceutical compounds containing them |
| 12/25/2008 | US20080319198 N-benzyl-N-{2-[7-(4-cyanobenzyl)-9-oxa-3,7-diazabicyclo[3.3.1]non-3-yl]ethyl}methane-sulfonamide; trial and ventricular arrhythmias; pharmacokinetics; electrophysiological activity; lowering daily clinical dose, lengthening duration of action; side effect reduction |
| 12/25/2008 | US20080319052 Lipopexia Inhibitor and Food or Beverage |
| 12/25/2008 | US20080319042 Compositions and methods for treatment of liver disease |
| 12/25/2008 | US20080318877 Purifications of pomegranate ellagitannins and their uses thereof |
| 12/25/2008 | US20080318255 Fluorescent Labeled Sphingosines |
| 12/25/2008 | US20080317692 Suicide substrates of tyrosinase and use thereof |
| 12/24/2008 | WO2008157552A2 Invertebrate acetylcholinesterase inhibitors |
| 12/24/2008 | WO2008155890A1 Method for producing glycoside aglycone |
| 12/24/2008 | WO2008155393A1 Use of oxygenated heterocycles chosen from xanthones and biflavonoids for the preparation of a composition intended to act as an anti-coccidial agent |
| 12/24/2008 | WO2007096449A8 Method for obtaining polyphenol-rich cocoa powder with a low fat content and cocoa thus obtained |
| 12/24/2008 | EP1545502A4 Keto cannabinoids with therapeutic indications |
| 12/24/2008 | CN101331137A Antitumour compounds |
| 12/24/2008 | CN101331124A Novel vanilloid receptor ligands and their use for producing medicaments |
| 12/24/2008 | CN101328164A Method for preparing xanthydrol from xanthones as raw material |
| 12/24/2008 | CN101328163A Compounds, compositions and methods |
| 12/24/2008 | CN101328162A Use of citrus aurtantium extract hydration meranzin for preparing gastrointestinal dynamic promoting drugs and preparation |
| 12/24/2008 | CN101328161A Method for separating and detecting nebivolol hydrochloride impurity by liquid phase chromatography |
| 12/24/2008 | CN100445272C Non-steroidal (hetero) cyclically substd. acylanilides with mixed gestagen and androgen activity |
| 12/23/2008 | US7468462 Modulate activity of Nuclear Retinoid receptors; regulating cell differentiation and cell cycle processes and cellular signaling processes regulated by thyroid hormone, vitamin D, all-trans retinoic acid; 2-[6-(3-Adamantan-1-yl-4-methoxyphenyl)-naphthalen-2-yl]-3-hydroxy-cyclopent-2-enone |
| 12/23/2008 | US7468445 treating symptoms of one or more of the following medical conditions: amebic infections, giardiasis, estrogen deficient states, osteoporosis, cardiovascular heart disease, high cholesterol levels, hyperlipidemia, cancer by administering to a subject having, or predisposed to, one or more of the conditio |
| 12/23/2008 | CA2348028C Method of preparing delta-9-tetrahydrocannabinol |
| 12/18/2008 | WO2008153938A2 Epigallocatechin-3-gallate crystal compositions |
| 12/18/2008 | WO2008153629A1 Skin lightening compositions and methods |
| 12/18/2008 | WO2008152159A2 6 -acyloxy- 7-meth0xy- 2, 2 -dimethylchromane compounds and their use as pigmentation-regulators |
| 12/18/2008 | WO2008130321A3 Novel n-tetrahydronaphtalene or 5-heterocyclyl-chromane or 8-heterocyclyl-tetrahydronaphtalene derivatives for the treatment of pain |
| 12/18/2008 | WO2008130319A3 Novel n-tetrahydronaphtalene or n-chromane carboxamide derivatives for the treatment of pain |
| 12/18/2008 | US20080312458 Reactivity of Hydroxymethylglutaryl Coenzyme A (HMG-CoA) Reductase Inhibitors Containing Conjugated Dienes with Phenolic Antioxidants in the Solid-State |
| 12/18/2008 | US20080312316 Chromone Derivatives Useful as Antagonists of Vr1 Receptors |
| 12/18/2008 | US20080312312 For treating prostate cancer; (6S,6aR,10aS)-2-Hydroxy-6-(4-hydroxy-phenyl)-6,6a,7,8,10,10a-hexahydro-benzo[c]chromen-9-one; testicular cancer, cardiovascular diseases, neurodegenerative disorders, urinary incontinence, central nervous system disorders, gastrointestinal tract disorders, osteoporosis |
| 12/18/2008 | US20080312233 Therapeutic Morpholino-Substituted Compounds |
| 12/18/2008 | US20080312224 Oxaphenanthrene Derivatives |
| 12/17/2008 | EP2001860A2 19-nor-vitamin d analogs with 1,2,or 3,2 heterocyclic ring |
| 12/17/2008 | EP2001844A2 Bicyclic carboxylic acid derivatives useful for treating metabolic disorders |
| 12/17/2008 | EP2001472A2 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use |
| 12/17/2008 | EP1763520B1 Use of trisubstituted benzopyranones |
| 12/17/2008 | CN101326174A Compound having hydrocoumarin skeleton, liquid crystal composition and liquid crystal display element |
| 12/17/2008 | CN101323607A Preparation of high content mixed tocopherols |
| 12/17/2008 | CN101323606A Extraction and purification method of sesquiterpenes coumarin ether and use thereof |
| 12/17/2008 | CN101322748A Hypericum perforatum total flavones and formulation preparation and quality testing method |
| 12/17/2008 | CN100443486C 7-esterified and 7,20-double esterified camptothecine derivant and method for preparing the same and pharmaceutical combination and uses thereof |
| 12/17/2008 | CN100443480C Tricyclic compound and its preparation and use |
| 12/16/2008 | US7465814 Sulfonate compound and fluorescent probe using the same |